Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters

Yan Ru Su, Hiroyuki Ishiguro, Amy S. Major, Dwayne E. Dove, Wenwu Zhang, Alyssa H. Hasty, Vladimir R. Babaev, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The antiatherogenic effect of high-density lipoprotein (HDL) and its major protein component apolipoprotein A-I (apoA-I) has been largely attributed to their key roles in reverse cholesterol transport (RCT) and cellular cholesterol efflux. Substantial evidence shows that overexpression of human apoA-I reduces atherosclerosis in animal models. However, it is uncertain whether this protection is due to an increase in plasma HDL level or to a local effect in the artery wall. To test the hypothesis that expression of human apoA-I in macrophages can promote RCT in the artery wall, we used a retroviral construct expressing human apoA-I cDNA (MFG-HAI) to transduce ApoE-/- bone marrow cells and then transplanted these cells into ApoE-/- mice with preexisting atherosclerosis. ApoE-/- mice reconstituted with MFG-HAI marrow had a significant reduction (30%) in atherosclerotic lesions in the proximal aorta compared to control mice that received marrow expressing MFG parental virus. Peritoneal macrophages isolated from MFG-HAI mice showed a four- to fivefold increase in mRNA expression levels of both ATP-binding cassette (ABC) A1 and ABCG1 compared to controls. Our data demonstrate that gene transfer-mediated expression of human apoA-I in macrophages can compensate in part for apoE deficiency and delay the progression of atherosclerotic lesions by stimulating ABC-dependent cholesterol efflux and RCT.

Original languageEnglish (US)
Pages (from-to)576-583
Number of pages8
JournalMolecular Therapy
Volume8
Issue number4
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

ATP-Binding Cassette Transporters
Apolipoprotein A-I
Apolipoproteins E
Atherosclerosis
Up-Regulation
Macrophages
Cholesterol
HDL Lipoproteins
Arteries
Adenosine Triphosphate
Bone Marrow
Peritoneal Macrophages
Bone Marrow Cells
Aorta
Animal Models
Complementary DNA
Viruses
Messenger RNA
human APOA1 protein
Genes

Keywords

  • ABCA1
  • ABCG1
  • Apolipoprotein A-I
  • Apolipoprotein E deficiency
  • Atherosclerosis
  • Bone marrow transplantation
  • Cholesterol efflux
  • Gene therapy
  • Macrophages
  • Retrovirus
  • Reverse cholesterol transport

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. / Su, Yan Ru; Ishiguro, Hiroyuki; Major, Amy S.; Dove, Dwayne E.; Zhang, Wenwu; Hasty, Alyssa H.; Babaev, Vladimir R.; Linton, MacRae F.; Fazio, Sergio.

In: Molecular Therapy, Vol. 8, No. 4, 10.2003, p. 576-583.

Research output: Contribution to journalArticle

Su, Yan Ru ; Ishiguro, Hiroyuki ; Major, Amy S. ; Dove, Dwayne E. ; Zhang, Wenwu ; Hasty, Alyssa H. ; Babaev, Vladimir R. ; Linton, MacRae F. ; Fazio, Sergio. / Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. In: Molecular Therapy. 2003 ; Vol. 8, No. 4. pp. 576-583.
@article{0f5984a8c01d47c4a50c218933ab5e3d,
title = "Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters",
abstract = "The antiatherogenic effect of high-density lipoprotein (HDL) and its major protein component apolipoprotein A-I (apoA-I) has been largely attributed to their key roles in reverse cholesterol transport (RCT) and cellular cholesterol efflux. Substantial evidence shows that overexpression of human apoA-I reduces atherosclerosis in animal models. However, it is uncertain whether this protection is due to an increase in plasma HDL level or to a local effect in the artery wall. To test the hypothesis that expression of human apoA-I in macrophages can promote RCT in the artery wall, we used a retroviral construct expressing human apoA-I cDNA (MFG-HAI) to transduce ApoE-/- bone marrow cells and then transplanted these cells into ApoE-/- mice with preexisting atherosclerosis. ApoE-/- mice reconstituted with MFG-HAI marrow had a significant reduction (30{\%}) in atherosclerotic lesions in the proximal aorta compared to control mice that received marrow expressing MFG parental virus. Peritoneal macrophages isolated from MFG-HAI mice showed a four- to fivefold increase in mRNA expression levels of both ATP-binding cassette (ABC) A1 and ABCG1 compared to controls. Our data demonstrate that gene transfer-mediated expression of human apoA-I in macrophages can compensate in part for apoE deficiency and delay the progression of atherosclerotic lesions by stimulating ABC-dependent cholesterol efflux and RCT.",
keywords = "ABCA1, ABCG1, Apolipoprotein A-I, Apolipoprotein E deficiency, Atherosclerosis, Bone marrow transplantation, Cholesterol efflux, Gene therapy, Macrophages, Retrovirus, Reverse cholesterol transport",
author = "Su, {Yan Ru} and Hiroyuki Ishiguro and Major, {Amy S.} and Dove, {Dwayne E.} and Wenwu Zhang and Hasty, {Alyssa H.} and Babaev, {Vladimir R.} and Linton, {MacRae F.} and Sergio Fazio",
year = "2003",
month = "10",
doi = "10.1016/S1525-0016(03)00214-4",
language = "English (US)",
volume = "8",
pages = "576--583",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters

AU - Su, Yan Ru

AU - Ishiguro, Hiroyuki

AU - Major, Amy S.

AU - Dove, Dwayne E.

AU - Zhang, Wenwu

AU - Hasty, Alyssa H.

AU - Babaev, Vladimir R.

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2003/10

Y1 - 2003/10

N2 - The antiatherogenic effect of high-density lipoprotein (HDL) and its major protein component apolipoprotein A-I (apoA-I) has been largely attributed to their key roles in reverse cholesterol transport (RCT) and cellular cholesterol efflux. Substantial evidence shows that overexpression of human apoA-I reduces atherosclerosis in animal models. However, it is uncertain whether this protection is due to an increase in plasma HDL level or to a local effect in the artery wall. To test the hypothesis that expression of human apoA-I in macrophages can promote RCT in the artery wall, we used a retroviral construct expressing human apoA-I cDNA (MFG-HAI) to transduce ApoE-/- bone marrow cells and then transplanted these cells into ApoE-/- mice with preexisting atherosclerosis. ApoE-/- mice reconstituted with MFG-HAI marrow had a significant reduction (30%) in atherosclerotic lesions in the proximal aorta compared to control mice that received marrow expressing MFG parental virus. Peritoneal macrophages isolated from MFG-HAI mice showed a four- to fivefold increase in mRNA expression levels of both ATP-binding cassette (ABC) A1 and ABCG1 compared to controls. Our data demonstrate that gene transfer-mediated expression of human apoA-I in macrophages can compensate in part for apoE deficiency and delay the progression of atherosclerotic lesions by stimulating ABC-dependent cholesterol efflux and RCT.

AB - The antiatherogenic effect of high-density lipoprotein (HDL) and its major protein component apolipoprotein A-I (apoA-I) has been largely attributed to their key roles in reverse cholesterol transport (RCT) and cellular cholesterol efflux. Substantial evidence shows that overexpression of human apoA-I reduces atherosclerosis in animal models. However, it is uncertain whether this protection is due to an increase in plasma HDL level or to a local effect in the artery wall. To test the hypothesis that expression of human apoA-I in macrophages can promote RCT in the artery wall, we used a retroviral construct expressing human apoA-I cDNA (MFG-HAI) to transduce ApoE-/- bone marrow cells and then transplanted these cells into ApoE-/- mice with preexisting atherosclerosis. ApoE-/- mice reconstituted with MFG-HAI marrow had a significant reduction (30%) in atherosclerotic lesions in the proximal aorta compared to control mice that received marrow expressing MFG parental virus. Peritoneal macrophages isolated from MFG-HAI mice showed a four- to fivefold increase in mRNA expression levels of both ATP-binding cassette (ABC) A1 and ABCG1 compared to controls. Our data demonstrate that gene transfer-mediated expression of human apoA-I in macrophages can compensate in part for apoE deficiency and delay the progression of atherosclerotic lesions by stimulating ABC-dependent cholesterol efflux and RCT.

KW - ABCA1

KW - ABCG1

KW - Apolipoprotein A-I

KW - Apolipoprotein E deficiency

KW - Atherosclerosis

KW - Bone marrow transplantation

KW - Cholesterol efflux

KW - Gene therapy

KW - Macrophages

KW - Retrovirus

KW - Reverse cholesterol transport

UR - http://www.scopus.com/inward/record.url?scp=0142244101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142244101&partnerID=8YFLogxK

U2 - 10.1016/S1525-0016(03)00214-4

DO - 10.1016/S1525-0016(03)00214-4

M3 - Article

C2 - 14529830

AN - SCOPUS:0142244101

VL - 8

SP - 576

EP - 583

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 4

ER -